Bulletin

Endo outbids Valeant with $15.7bn Salix offer as drug sector heats up

Pharmacy

Ireland-based pharmaceuticals group Endo has moved to gatecrash Valeant's takeover bid for US gastrointestinal drugmaker Salix by making its own $15.7bn approach, compared with Valeant's $14.5bn offer. The activity is a further sign of the frenetic pace of deal making in the drugs industry, which last week saw AbbVie win a three-way fight for Pharmacyclics, a biotech company that makes a single cancer drug, with a $21bn offer. Almost $70bn of deals have been unveiled in pharma and biotech this year, according to Thomson Reuters, double the level of activity at the same point in 2014. Since the start of 2014, the global healthcare sector has seen $475bn of deals. Quebec-based Valeant had said it would use its non-US domicile and ultra-low tax rate to extract value from the deal, with the combined company enjoying a tax rate of 5%, compared to around 30% for Salix. Endo would be able to make similar savings after reincorporating in Ireland last year.

 

Note: News bulletin content has been provided by a third-party and is not the opinion of Santander.

Other Articles

GoJumpIn

The sky is seemingly the limit for a company which has got us all jumping with excitement as they secure a Santander funding deal to make…

Bulletin
Food and drink exporting opportunities in the UAE

Richard Cuda, Director - Strategic Banking Alliances, International, Santander UK says UK food and drink manufacturers should seriously…

Bulletin

According to DIT, of the 2.5 million businesses registered in the UK, an estimated 360,000 who have an exportable product or service…

Bulletin
Food and drink exporting opportunities in the UAE

Richard Cuda, Director - Strategic Banking Alliances, International, Santander UK says UK food and drink manufacturers should seriously…

Bulletin

According to DIT, of the 2.5 million businesses registered in the UK, an estimated 360,000 who have an exportable product or service…

Bulletin
Cardiff-based Forward Waste Management

Money will support the company, which serves the manufacturing sector, with Welsh and West Midland growth plans.

Bulletin

Where Next?